CaP-based anti-inflammatory HIF-1α siRNA-encapsulating nanoparticle for rheumatoid arthritis therapy

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

(2020) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Vaccarin prevents titanium particle-induced osteolysis and inhibits RANKL-induced osteoclastogenesis by blocking NF-κB and MAPK signaling pathways

(2019) Yun Liu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Dual delivery of nucleic acids and PEGylated-bisphosphonates via calcium phosphate nanoparticles

(2019) Sofia Bisso et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Anti-Inflammatory Effects of HDL (High-Density Lipoprotein) in Macrophages Predominate Over Proinflammatory Effects in Atherosclerotic Plaques

(2019) Panagiotis Fotakis et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Regulation of immune response by bioactive ions released from silicate bioceramics for bone regeneration

(2018) Yan Huang et al.   Acta Biomaterialia

Signaling Pathways in Inflammation and Anti-inflammatory Therapies

(2018) Yiu To Yeung et al.   CURRENT PHARMACEUTICAL DESIGN

Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate

(2018) Abdulaziz M. Aldayel et al.   JOURNAL OF CONTROLLED RELEASE

Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways

(2018) Qiang Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease

(2018) A.David Marais   PATHOLOGY

Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB

(2017) Leen Catrysse et al.   TRENDS IN CELL BIOLOGY

Anti-rheumatic drug iguratimod protects against cancer-induced bone pain and bone destruction in a rat model

(2017) Yue Sun et al.   Oncology Letters

Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis

(2017) Jia-Lin Huang et al.   Nature Communications

Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)

(2016) Hyun Seung Ban et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Hypoxia-inducible factors: key regulators of myeloid cells during inflammation

(2016) Nan Lin et al.   JOURNAL OF CLINICAL INVESTIGATION

The current economic burden of illness of osteoporosis in Canada

(2016) R. B. Hopkins et al.   OSTEOPOROSIS INTERNATIONAL

Biologic Agents in Rheumatoid Arthritis: An Update for Managed Care Professionals

(2016) Sandeep K. Agarwal   JOURNAL OF MANAGED CARE PHARMACY

Transfection System of Amino-Functionalized Calcium Phosphate Nanoparticles: In Vitro Efficacy, Biodegradability, and Immunogenicity Study

(2015) Babak Mostaghaci et al.   ACS Applied Materials & Interfaces

The pathogenic role of angiogenesis in rheumatoid arthritis

(2015) Hatem A. Elshabrawy et al.   ANGIOGENESIS

Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer

(2015) Wei-Hua Chen et al.   CANCER LETTERS

Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis

(2015) Fanlei Hu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Modulation of the osteoconductive property and immune response of poly(ether ether ketone) by modification with calcium ions

(2015) R. Toita et al.   Journal of Materials Chemistry B

Therapeutic targets for rheumatoid arthritis: Progress and promises

(2014) Abdullah Alghasham et al.   AUTOIMMUNITY

The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling

(2014) Zanjing Zhai et al.   BIOMATERIALS

HIF Transcription Factors, Inflammation, and Immunity

(2014) Asis Palazon et al.   IMMUNITY

High-density lipoproteins for the systemic delivery of short interfering RNA

(2013) Kaylin Marie McMahon et al.   Expert Opinion on Drug Delivery

Current immunotherapy in rheumatoid arthritis

(2013) Florian MP Meier et al.   Immunotherapy

Silencing TNF-α in macrophages and dendritic cells for arthritis treatment

(2013) C Ye et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis

(2012) Sofia Konisti et al.   Nature Reviews Rheumatology

Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment

(2012) Georg Schett et al.   Nature Reviews Rheumatology

Apolipoprotein E Gene Polymorphisms Are Strong Predictors of Inflammation and Dyslipidemia in Rheumatoid Arthritis

(2011) T. E. TOMS et al.   JOURNAL OF RHEUMATOLOGY

Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T Cells

(2010) Guangjie Chen   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Rheumatoid arthritis

(2010) David L Scott et al.   LANCET

The Role of NF-κB in Hypoxia-Induced Gene Expression

(2009) Cormac T. Taylor et al.   Annals of the New York Academy of Sciences

Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm

(2009) Jonathan Golledge et al.   ATHEROSCLEROSIS

Hypoxia. Regulation of NFκB signalling during inflammation: the role of hydroxylases

(2009) Kathryn M Oliver et al.   ARTHRITIS RESEARCH & THERAPY

Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption

(2008) Susan R. Wilson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MMP-9 mRNA as a Therapeutic Marker in Acute and Chronic Stages of Arthritis Induced by Type II Collagen Antibody

(2008) Wei-Tso Chia et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α

(2008) Jordi Rius et al.   NATURE